{"disease":{"id":"malignant-tumors","name":"malignant tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07026370","title":"Chinese Population Health and Multimorbidity Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50991,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT05794841","title":"Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT03739827","title":"Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07072143","title":"An International Study on Pediatric Patients With Rare Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07409415","title":"A Real-World Study on the Efficacy, Safety, and Quality of Life of Different Treatment Approaches for Post-Chemotherapy Neutropenia in Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03959800","title":"Molecular Basis of Pediatric Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT06702566","title":"The Effect of Serum Ferritin in irAE","phase":"NA","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT03141021","title":"Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1050,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07132606","title":"The Predictive Value of Serum Histone Succinylation in Malignant Solid Tumors","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Yinghua Ji","has_results":false},{"nct_id":"NCT06914700","title":"A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT07307053","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07237204","title":"15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT07480733","title":"Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":480,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT05779163","title":"A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":468,"lead_sponsor_name":"Nanjing Leads Biolabs Co.,Ltd","has_results":false},{"nct_id":"NCT06764771","title":"A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":437,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06877650","title":"First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":436,"lead_sponsor_name":"Shanghai JMT-Bio Inc.","has_results":false},{"nct_id":"NCT06770881","title":"JSKN033 in Chinese Subjects with Advanced Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":430,"lead_sponsor_name":"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT07287995","title":"A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":428,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT06683846","title":"Ivonescimab in the Treatment of Multiple Advanced Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06772376","title":"SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Fuzhou General Hospital","has_results":false},{"nct_id":"NCT05728541","title":"Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":367,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06115642","title":"A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT05245500","title":"Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":336,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT04225117","title":"A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":329,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT06816212","title":"Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":280,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT02601950","title":"A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"Epizyme, Inc.","has_results":true},{"nct_id":"NCT06464055","title":"A Study of GQ1010 in Subjects With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"GeneQuantum Healthcare (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT04708210","title":"Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":256,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT02838602","title":"Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05622409","title":"A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"National Health Research Institutes, Taiwan","has_results":false},{"nct_id":"NCT04956926","title":"Clinical Study of JS201 in Patients With Advanced Malignant Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":244,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT05198817","title":"A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT02058745","title":"SmartCare: Innovations in Caregiving Interventions","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT03611868","title":"A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Ascentage Pharma Group Inc.","has_results":false},{"nct_id":"NCT07292402","title":"JSKN022 in Subjects With Advanced Malignant Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT02091999","title":"A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT06775587","title":"SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Fuzhou General Hospital","has_results":false},{"nct_id":"NCT06759649","title":"A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Compugen Ltd","has_results":false},{"nct_id":"NCT02709889","title":"Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":200,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03110783","title":"Bioseal Dural Sealing Study BIOS-14-001","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Guangzhou Bioseal Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT02162732","title":"Molecular-Guided Therapy for Childhood Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Giselle Sholler","has_results":true},{"nct_id":"NCT06251050","title":"A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06285591","title":"Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07158710","title":"Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":159,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05214482","title":"A Study of AK112 in Advanced Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Akeso","has_results":false},{"nct_id":"NCT05229497","title":"A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":154,"lead_sponsor_name":"Akeso","has_results":false},{"nct_id":"NCT06944444","title":"A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":154,"lead_sponsor_name":"Shenyang Sunshine Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT06962553","title":"Nurses' Competence and Role in Survival Prediction and Prognostic Communication","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":152,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07436728","title":"A Study of TAK-505 in Adults With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":151,"lead_sponsor_name":"Takeda","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}